![](https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/26408649c7b1ab26159fa2d5e110c51fcf81021c-5000x2802.jpg?fit=crop&auto=format)
Study Shows Value of Investing in Pharmacogenomics Testing for Tacrolimus Dosing in Kidney Transplant Recipients
The cost of pharmacogenomic (PGx) testing is often a barrier to more widespread implementation of preemptive PGx testing in clinical practice, and more cost effectiveness data is crucial in advocating for better insurance coverage in the United States. …